Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study

References

• Aiba T, Susa M, Fukumori S, Hashimoto Y. (2005). The effects of culture conditions on CYP3A4 and MDR1 mRNA induction by 1alpha,25-dihydroxyvitamin D(3) in human intestinal cell lines, Caco-2 and LS180. Drug Metab Pharmacokinet 20:268–274.
   PubMedGoogle Scholar
• Bachmann K, Patel H, Batayneh Z, Slama J, White D, Posey J, Ekins S, Gold D, Sambucetti L. (2004). PXR and the regulation of apoA1 and HDL-cholesterol in rodents. Pharmacol Res 50:237–246.
   PubMed Web of Science ®Google Scholar
• Barwick JL, Quattrochi LC, Mills AS, Potenza C, Tukey RH, Guzelian PS. (1996). Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol Pharmacol 50:10–16.
   PubMed Web of Science ®Google Scholar
• Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Bäckman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. (1998). Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208–12213.
   PubMed Web of Science ®Google Scholar
• Biggs JS, Wan J, Cutler NS, Hakkola J, Uusimäki P, Raunio H, Yost GS. (2007). Transcription factor binding to a putative double E-box motif represses CYP3A4 expression in human lung cells. Mol Pharmacol 72:514–525.
   Google Scholar
• Brobst DE, Ding X, Creech KL, Goodwin B, Kelley B, Staudinger JL. (2004). Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther 310:528–535.
   PubMed Web of Science ®Google Scholar
• Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E, Avery BA, Avery MA, Fromm MF, Eichelbaum M. (2005). Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 67:1954–1965.
   PubMed Web of Science ®Google Scholar
• Cerveny L, Svecova L, Anzenbacherova E, Vrzal R, Staud F, Dvorak Z, Ulrichova J, Anzenbacher P, Pavek P. (2007). Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 35:1032–1041.
   PubMed Web of Science ®Google Scholar
• Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR. (2005). Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Mol Endocrinol 19:1125–1134.
   PubMed Web of Science ®Google Scholar
• Das BC, Madhukumar AV, Anguiano J, Kim S, Sinz M, Zvyaga TA, Power EC, Ganellin CR, Mani S. (2008). Synthesis of novel ketoconazole derivatives as inhibitors of the human pregnane X receptor (PXR; NR1I2; also termed SXR, PAR). Bioorg Med Chem Lett 18:3974–3977.
   PubMed Web of Science ®Google Scholar
• Dring AM, Anderson LE, Qamar S, Stoner MA. (2010). Rational quantitative structure–activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands. Chem Biol Interact, 188:512–525.
   Google Scholar
• Ekins S, Andreyev S, Ryabov A, Kirillov E, Rakhmatulin EA, Sorokina S, Bugrim A, Nikolskaya T. (2006). A combined approach to drug metabolism and toxicity assessment. Drug Metab Dispos 34:495–503.
   PubMed Web of Science ®Google Scholar
• Ekins S, Chang C, Mani S, Krasowski MD, Reschly EJ, Iyer M, Kholodovych V, Ai N, Welsh WJ, Sinz M, Swaan PW, Patel R, Bachmann K. (2007). Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol Pharmacol 72:592–603.
   PubMed Web of Science ®Google Scholar
• Ekins S, Erickson JA. (2002). A pharmacophore for human pregnane X receptor ligands. Drug Metab Dispos 30:96–99.
   PubMed Web of Science ®Google Scholar
• Ekins S, Kortagere S, Iyer M, Reschly EJ, Lill MA, Redinbo MR, Krasowski MD. (2009). Challenges predicting ligand–receptor interactions of promiscuous proteins: the nuclear receptor PXR. PLoS Comput Biol 5:e1000594.
   PubMed Web of Science ®Google Scholar
• Ekins S, Mirny L, Schuetz EG. (2002). A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta. Pharm Res 19:1788–1800.
   PubMed Web of Science ®Google Scholar
• Ernst E. (2003). Herbal medicines put into context. BMJ 327:881–882.
   PubMed Web of Science ®Google Scholar
• Faucette SR, Sueyoshi T, Smith CM, Negishi M, Lecluyse EL, Wang H. (2006). Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J Pharmacol Exp Ther 317:1200–1209.
   PubMed Web of Science ®Google Scholar
• Fugh-Berman A. (2000). Herb–drug interactions. Lancet 355:134–138.
   PubMed Web of Science ®Google Scholar
• Gao YD, Olson SH, Balkovec JM, Zhu Y, Royo I, Yabut J, Evers R, Tan EY, Tang W, Hartley DP, Mosley RT. (2007). Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach. Xenobiotica 37:124–138.
   PubMed Web of Science ®Google Scholar
• Ghose R, Guo T, Haque N. (2009). Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. Arch Biochem Biophys 481:123–130.
   PubMed Web of Science ®Google Scholar
• Gibson GG, Plant NJ, Swales KE, Ayrton A, El-Sankary W. (2002). Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32:165–206.
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, D’Costa DJ, Robertson GR, Liddle C. (2002). Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor. Mol Pharmacol 62:359–365.
   PubMed Web of Science ®Google Scholar
• Goodwin B, Hodgson E, Liddle C. (1999). The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329–1339.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (1999). Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1–17.
   PubMed Web of Science ®Google Scholar
• Hariparsad N, Chu X, Yabut J, Labhart P, Hartley DP, Dai X, Evers R. (2009). Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes. Nucleic Acids Res 37:1160–1173.
   PubMed Web of Science ®Google Scholar
• Harris AJ, Dial SL, Casciano DA. (2004). Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat Res 549:79–99.
   PubMed Web of Science ®Google Scholar
• Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S, Kamataki T. (1993). Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. Eur J Biochem 218:585–595.
   PubMedGoogle Scholar
• Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S. (2005). Herb–drug interactions: a literature review. Drugs 65:1239–1282.
   PubMed Web of Science ®Google Scholar
• Huang H, Wang H, Sinz M, Zoeckler M, Staudinger J, Redinbo MR, Teotico DG, Locker J, Kalpana GV, Mani S. (2007). Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole. Oncogene 26:258–268.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. (2007). Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol Ther 116:496–526.
   PubMed Web of Science ®Google Scholar
• Istrate MA, Nussler AK, Eichelbaum M, Burk O. (2010). Regulation of CYP3A4 by pregnane X receptor: the role of nuclear receptors competing for response element binding. Biochem Biophys Res Commun 393:688–693.
   PubMed Web of Science ®Google Scholar
• Johnson DR, Li CW, Chen LY, Ghosh JC, Chen JD. (2006). Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT). Mol Pharmacol 69:99–108.
   PubMed Web of Science ®Google Scholar
• Khandelwal A, Krasowski MD, Reschly EJ, Sinz MW, Swaan PW, Ekins S. (2008). Machine learning methods and docking for predicting human pregnane X receptor activation. Chem Res Toxicol 21:1457–1467.
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterström RH, Perlmann T, Lehmann JM. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73–82.
   PubMed Web of Science ®Google Scholar
• Konno Y, Kodama S, Moore R, Kamiya N, Negishi M. (2009). Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation. Mol Pharmacol 75:265–271.
   PubMed Web of Science ®Google Scholar
• Kuo YH, Lin YL, Don MJ, Chen RM, Ueng YF. (2006). Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza. J Pharm Pharmacol 58:521–527.
   PubMed Web of Science ®Google Scholar
• Lamba V, Panetta JC, Strom S, Schuetz EG. (2010). Genetic predictors of interindividual variability in hepatic CYP3A4 expression. J Pharmacol Exp Ther 332:1088–1099.
   PubMed Web of Science ®Google Scholar
• Lau AJ, Yang G, Rajaraman G, Baucom CC, Chang TK. (2010). Human Pregnane X Receptor agonism by Ginkgo biloba extract: assessment of the role of individual ginkgolides. J Pharmacol Exp Ther, 335:771–780.
   PubMed Web of Science ®Google Scholar
• Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016–1023.
   PubMed Web of Science ®Google Scholar
• Li CW, Dinh GK, Chen JD. (2009). Preferential physical and functional interaction of pregnane X receptor with the SMRTalpha isoform. Mol Pharmacol 75:363–373.
   PubMed Web of Science ®Google Scholar
• Lichti-Kaiser K, Staudinger JL. (2008). The traditional Chinese herbal remedy tian xian activates pregnane X receptor and induces CYP3A gene expression in hepatocytes. Drug Metab Dispos 36:1538–1545.
   PubMed Web of Science ®Google Scholar
• Liguori MJ, Blomme EA, Waring JF. (2008). Trovafloxacin-induced gene expression changes in liver-derived in vitro systems: comparison of primary human hepatocytes to HepG2 cells. Drug Metab Dispos 36:223–233.
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. (2001). Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol 41:535–567.
   PubMed Web of Science ®Google Scholar
• Liu FJ, Song X, Yang D, Deng R, Yan B. (2008). The far and distal enhancers in the CYP3A4 gene co-ordinate the proximal promoter in responding similarly to the pregnane X receptor but differentially to hepatocyte nuclear factor-4alpha. Biochem J 409:243–250.
   PubMed Web of Science ®Google Scholar
• Luo G, Guenthner T, Gan LS, Humphreys WG. (2004). CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development. Curr Drug Metab 5:483–505.
   PubMed Web of Science ®Google Scholar
• Martínez-Jiménez CP, Jover R, Donato MT, Castell JV, Gómez-Lechón MJ. (2007). Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 8:185–194.
   PubMed Web of Science ®Google Scholar
• Matsumura K, Saito T, Takahashi Y, Ozeki T, Kiyotani K, Fujieda M, Yamazaki H, Kunitoh H, Kamataki T. (2004). Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 65:326–334.
   PubMed Web of Science ®Google Scholar
• Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. (2008). Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med 14:1263–1269.
   PubMed Web of Science ®Google Scholar
• Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA. (2000). St. John’s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500–7502.
   PubMed Web of Science ®Google Scholar
• Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, Huang L, Yaramus M, Baum A, Venkataramanan R, Xie W. (2006). Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 316:1369–1377.
   PubMed Web of Science ®Google Scholar
• Nebert DW, Russell DW. (2002). Clinical importance of the cytochromes P450. Lancet 360:1155–1162.
   PubMed Web of Science ®Google Scholar
• Ngan CH, Beglov D, Rudnitskaya AN, Kozakov D, Waxman DJ, Vajda S. (2009). The structural basis of pregnane X receptor binding promiscuity. Biochemistry 48:11572–11581.
   PubMed Web of Science ®Google Scholar
• Olsavsky KM, Page JL, Johnson MC, Zarbl H, Strom SC, Omiecinski CJ. (2007). Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol 222:42–56.
   PubMed Web of Science ®Google Scholar
• Paine MF, Hart HL, Ludington SS, Haining RL, Rettie AE, Zeldin DC. (2006). The human intestinal cytochrome P450 “pie”. Drug Metab Dispos 34:880–886.
   PubMed Web of Science ®Google Scholar
• Pavek P, Pospechova K, Svecova L, Syrova Z, Stejskalova L, Blazkova J, Dvorak Z, Blahos J. (2010). Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene. Biochem Pharmacol 79:277–287.
   PubMed Web of Science ®Google Scholar
• Raynal C, Pascussi JM, Leguelinel G, Breuker C, Kantar J, Lallemant B, Poujol S, Bonnans C, Joubert D, Hollande F, Lumbroso S, Brouillet JP, Evrard A. (2010). Pregnane X receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation. Mol Cancer 9:46.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Donato MT, Boobis A, Edwards RJ, Watts PS, Castell JV, Gómez-Lechón MJ. (2002). Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 32:505–520.
   PubMed Web of Science ®Google Scholar
• Sane RS, Buckley DJ, Buckley AR, Nallani SC, Desai PB. (2008). Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells. Drug Metab Dispos 36:946–954.
   PubMed Web of Science ®Google Scholar
• Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. (2007). Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3:360–366.
   PubMed Web of Science ®Google Scholar
• Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Lown KS, Watkins PB. (1997). Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. Mol Pharmacol 51:741–754.
   PubMed Web of Science ®Google Scholar
• Schuster D, Langer T. (2005). The identification of ligand features essential for PXR activation by pharmacophore modeling. J Chem Inf Model 45:431–439.
   PubMed Web of Science ®Google Scholar
• Sivertsson L, Ek M, Darnell M, Edebert I, Ingelman-Sundberg M, Neve EP. (2010). CYP3A4 catalytic activity is induced in confluent Huh7 hepatoma cells. Drug Metab Dispos 38:995–1002.
   Google Scholar
• Svecova L, Vrzal R, Burysek L, Anzenbacherova E, Cerveny L, Grim J, Trejtnar F, Kunes J, Pour M, Staud F, Anzenbacher P, Dvorak Z, Pavek P. (2008). Azole antimycotics differentially affect rifampicin-induced pregnane X receptor-mediated CYP3A4 gene expression. Drug Metab Dispos 36:339–348.
   PubMed Web of Science ®Google Scholar
• Synold TW, Dussault I, Forman BM. (2001). The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584–590.
   PubMed Web of Science ®Google Scholar
• Takeshita A, Taguchi M, Koibuchi N, Ozawa Y. (2002). Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics. J Biol Chem 277:32453–32458.
   PubMed Web of Science ®Google Scholar
• Tegude H, Schnabel A, Zanger UM, Klein K, Eichelbaum M, Burk O. (2007). Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestine. Drug Metab Dispos 35:946–954.
   PubMed Web of Science ®Google Scholar
• The Pharmacopoeia Commission of the Chinese Ministry of Public Health. (2010). Chinese Pharmacopoeia. Beijing: Chinese Medicine Science and Technology Publishing House.
   Google Scholar
• Timsit YE, Negishi M. (2007). CAR and PXR: the xenobiotic-sensing receptors. Steroids 72:231–246.
   PubMed Web of Science ®Google Scholar
• Tompkins LM, Wallace AD. (2007). Mechanisms of cytochrome P450 induction. J Biochem Mol Toxicol 21:176–181.
   PubMed Web of Science ®Google Scholar
• Toriyabe T, Nagata K, Takada T, Aratsu Y, Matsubara T, Yoshinari K, Yamazoe Y. (2009). Unveiling a new essential cis element for the transactivation of the CYP3A4 gene by xenobiotics. Mol Pharmacol 75:677–684.
   PubMed Web of Science ®Google Scholar
• Ung CY, Li H, Yap CW, Chen YZ. (2007). In silico prediction of pregnane X receptor activators by machine learning approaches. Mol Pharmacol 71:158–168.
   PubMed Web of Science ®Google Scholar
• Verma S, Tabb MM, Blumberg B. (2009). Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer 9:3.
   PubMed Web of Science ®Google Scholar
• Vieth M, Hirst JD, Kolinski A, Brooks CL III. (1998). Assessing energy functions for flexible docking. J Comp Chem 19:1612–1622.
   Web of Science ®Google Scholar
• Wang CY, Li CW, Chen JD, Welsh WJ. (2006). Structural model reveals key interactions in the assembly of the pregnane X receptor/corepressor complex. Mol Pharmacol 69:1513–1517.
   PubMed Web of Science ®Google Scholar
• Watkins RE, Davis-Searles PR, Lambert MH, Redinbo MR. (2003a). Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol 331:815–828.
   PubMed Web of Science ®Google Scholar
• Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR. (2003b). 2.1 Å crystal structure of human PXR in complex with the St. John’s wort compound hyperforin. Biochemistry 42:1430–1438.
   PubMed Web of Science ®Google Scholar
• Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR. (2001). The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292:2329–2333.
   PubMed Web of Science ®Google Scholar
• Williams PA, Cosme J, Vinkovic DM, Ward A, Angove HC, Day PJ, Vonrhein C, Tickle IJ, Jhoti H. (2004). Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 305:683–686.
   PubMed Web of Science ®Google Scholar
• Wu B, Liu M, Zhang S. (2004). Dan Shen agents for acute ischaemic stroke. Cochrane Database Syst Rev CD004295.
   Google Scholar
• Wu G, Robertson DH, Brooks CL 3rd, Vieth M. (2003). Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem 24:1549–1562.
   PubMed Web of Science ®Google Scholar
• Xie W, Barwick JL, Downes M, Blumberg B, Simon CM, Nelson MC, Neuschwander-Tetri BA, Brunt EM, Guzelian PS, Evans RM. (2000). Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406:435–439.
   PubMed Web of Science ®Google Scholar
• Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR. (2007). Crystal structure of the pregnane X receptor–estradiol complex provides insights into endobiotic recognition. Mol Endocrinol 21:1028–1038.
   PubMed Web of Science ®Google Scholar
• Yeung EY, Sueyoshi T, Negishi M, Chang TK. (2008). Identification of Ginkgo biloba as a novel activator of pregnane X receptor. Drug Metab Dispos 36:2270–2276.
   PubMed Web of Science ®Google Scholar
• Yu C, Ye S, Sun H, Liu Y, Gao L, Shen C, Chen S, Zeng S. (2009). PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chem Biol Interact 177:58–64.
   PubMed Web of Science ®Google Scholar
• Zhang J, Kuehl P, Green ED, Touchman JW, Watkins PB, Daly A, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Wrighton SA, Hancock M, Kim RB, Strom S, Thummel K, Russell CG, Hudson JR Jr, Schuetz EG, Boguski MS. (2001). The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11:555–572.
   PubMedGoogle Scholar
• Zhou C, Poulton EJ, Grün F, Bammler TK, Blumberg B, Thummel KE, Eaton DL. (2007). The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 71:220–229.
   PubMed Web of Science ®Google Scholar
• Zhou L, Zuo Z, Chow MS. (2005). Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345–1359.
   PubMed Web of Science ®Google Scholar
• Zhou SF. (2008). Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 9:310–322.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Liu JP, Chowbay B. (2009). Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41:89–295.
   PubMed Web of Science ®Google Scholar